Clinical trial
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
NCT01553058 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- October 27, 2016
- Enrollment
- 97 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, psoriasis